Overview
Magnus Medical developed SAINT (Stanford Accelerated Intelligent Neuromodulation Therapy), a personalized TMS protocol that uses fMRI-guided targeting to deliver rapid antidepressant effects. Their system received FDA Breakthrough Device designation and aims to compress weeks of TMS treatment into days.
More in Brain-Computer Interfaces
Latest industry news
China Performs World's First Commercial BCI Implant, Marking a Pivotal Moment in the Global Brain-Computer Interface Race
2026-07-16 · Industry
NIH Confirms Brain-Computer Device Restores Speech in Human Patient
2026-07-15 · Research
Neurovalens Wins FDA Approval for Wearable PTSD Therapy Aimed at US Veterans
2026-07-14 · Policy
BRYM Raises €650K to Build Wearable Neurofeedback Platform for Consumer and Clinical Markets
2026-07-13 · Funding
Company details
Category
🧠 Brain-Computer Interfaces
Location
Burlingame, USA
Funding
Series B · $50M
Website
magnusmedical.comListed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →